TTN截短变异的阅读框修复恢复肌联蛋白数量与功能
本研究利用诱导多能干细胞和CRISPR技术构建携带扩张型心肌病相关TTN截短变异(A带或I带)的人心肌细胞模型,发现A带变异剂量依赖性损害心脏微组织收缩力、降低全长TTN水平并产生大量截短肽,而CRISPR修复阅读框可恢复全长TTN并改善肉瘤功能。
要点
- A带TTN截短变异比I带变异更严重损害肉瘤功能,与预估DCM致病性成比例。
- 仅A带变异产生截短肽,整合入肌原纤维样结构并损害肌原纤维生成。
- CRISPR阅读框修复可恢复TTN水平与功能,有望靶向约30%的DCM相关TTN变异。
核心结论
- A带TTN截短变异通过产生截短肽损害肌原纤维生成和肉瘤功能,CRISPR阅读框修复可恢复功能缺陷。
研究设计与样本
- 利用诱导多能干细胞和CRISPR技术构建携带DCM相关A带或I带TTN截短变异的人心肌细胞模型,并进行单细胞和3D仿生心脏微组织功能测定。
主要发现
- A带TTN截短变异剂量依赖性损害心脏微组织收缩力、降低全长TTN水平并产生大量截短肽。
- TTN截短肽整合入新生肌原纤维样结构并损害肌原纤维生成。
- 通过近端I带TTN截短变异进行CRISPR消融截短肽可部分恢复心脏微组织收缩力缺陷。
- 使用SpCas9和TTN变异特异性引导RNA进行基因组编辑可恢复TTN阅读框,增加全长TTN水平、减少截短肽并改善肉瘤功能。
临床怎么用
- CRISPR介导的阅读框修复可作为一次性基因组编辑策略,靶向约30%的DCM相关TTN截短变异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Titin truncation variants (TTNtvs) are the most common inheritable risk factor for dilated cardiomyopathy (DCM), a disease with high morbidity and mortality. The pathogenicity of TTNtvs has been associated with structural localization as A-band variants overlapping myosin heavy chain-binding domains are more pathogenic than I-band variants by incompletely understood mechanisms. Demonstrating why A-band variants are highly pathogenic for DCM could reveal new insights into DCM pathogenesis, titin (TTN) functions, and therapeutic targets. METHODS: We constructed human cardiomyocyte models harboring DCM-associated TTNtvs within A-band and I-band structural domains using induced pluripotent stem cell and CRISPR technologies. We characterized normal TTN isoforms and variant-specific truncation peptides by their expression levels and cardiomyocyte localization using TTN protein gel electrophoresis and immunofluorescence, respectively. Using CRISPR to ablate A-band variant-specific truncation peptides through introduction of a proximal I-band TTNtv, we studied genetic mechanisms in single cardiomyocyte and 3-dimensional, biomimetic cardiac microtissue functional assays. Last, we engineered a full-length TTN protein reporter assay and used next-generation sequencing assays to develop a CRISPR therapeutic for somatic cell genome editing TTNtvs. RESULTS: An A-band TTNtv dose-dependently impaired cardiac microtissue twitch force, reduced full-length TTN levels, and produced abundant TTN truncation peptides. TTN truncation peptides integrated into nascent myofibril-like structures and impaired myofibrillogenesis. CRISPR ablation of TTN truncation peptides using a proximal I-band TTNtv partially restored cardiac microtissue twitch force deficits. Cardiomyocyte genome editing using SpCas9 and a TTNtv-specific guide RNA restored the TTN protein reading frame, which increased full-length TTN protein levels, reduced TTN truncation peptides, and increased sarcomere function in cardiac microtissue assays. CONCLUSIONS: An A-band TTNtv diminished sarcomere function greater than an I-band TTNtv in proportion to estimated DCM pathogenicity. Although both TTNtvs resulted in full-length TTN haploinsufficiency, only the A-band TTNtv produced TTN truncation peptides that impaired myofibrillogenesis and sarcomere function. CRISPR-mediated reading frame repair of the A-band TTNtv restored functional deficits, and could be adapted as a one-and-done genome editing strategy to target ≈30% of DCM-associated TTNtvs.
引用
- Romano R, Ghahremani S, Zimmerman T, et al. Reading Frame Repair of TTN Truncation Variants Restores Titin Quantity and Functions. Circulation. 2021. PMID: 34905694. doi:10.1161/CIRCULATIONAHA.120.049997
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。